StockDuty ← Dashboard Sep 22, 2026 01:30 AM ET
SignalCorporate

ELI LILLY CEO TELLS CNBC ONE-THIRD OF NEW GLP-1 PILL PATIENTS ARE TAKING FOUNDAYO, AS DRUGMAKER RAMPS UP PRODUCTION - CNBC

Eli Lilly CEO reports one-third of new GLP-1 pill patients on Foundayo amid production ramp-up.

Eli Lilly CEO reports one-third of new GLP-1 pill patients on Foundayo amid production ramp-up.
Eli Lilly CEO reports one-third of new GLP-1 pill patients on Foundayo amid production ramp-up. — impact context not separately stored; see What changed.
Sources